Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Recognition from the United Nations and MACE
2013-11-22

 
The University of the Free State received Excellence and Merit awards for its communication and marketing projects.
From the left is Leatitia Pienaar, editor of Bult magazine, Lacea Loader, Director Strategic Communication, Leonie Bolleurs, editor of Dumela and Ilze Bakkes, UFS Marketer: Publications and Broadcast.
Photo: Sonia Small

The University of the Free State (UFS) was this week recognised by the United Nations (UN), as well as the national association for Marketing, Advancement and Communication in Education (MACE), for its communication and marketing publications and campaigns.

The UFS was named by representatives of the UN to receive a special United Nations Award for a leadership communication campaign called ‘Talk to me’. The award, which forms part of the Golden Awards of the International Public Relations Association (IPRA), is made annually to the campaign that best supports human development in line with the UN objectives.

The UFS also received seven awards from MACE during the Higher and Further Education Excellence Awards. The ‘Talk to me’ campaign was awarded an Excellence Award in the category integrated campaigns and projects; a television campaign on DSTV received an Excellence Award in the broadcasting category. The campaign also received an award as the overall winner in this category. The magazine Bult received a special Excellence Award in the category external publications (as the publication with the highest marks in the history of this award ceremony); the staff newsletter Dumela and a set of student recruitment publications each received a Merit Award in the categories internal newsletters and special publications respectively; and the Open Day campaign received a Merit Award in the category integrated campaigns and projects.

The Excellence Awards form part of the 2013 national MACE congress, which was hosted by the UFS on the Bloemfontein Campus from 18-20 November 2013 and attended by 139 delegates from 25 higher and further education institutions.

“I am extremely proud of the achievements of what is emerging as a truly world-class communications department at the UFS recognised increasingly for achievements nationally and abroad,” says Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS.

‘Talk to me’, which was implemented in 2010, is a leadership communication campaign that creates a way for staff and students to engage with Prof Jansen. With the campaign, he regularly spends time physically sitting on the university’s three campuses in a predetermined area giving staff and students the opportunity to talk and interact with him. The success of the campaign stems from the fact that it gives him the opportunity to pick up on issues or concerns of the campus community.

“The ‘Talk to me’ campaign is one of the key campaigns of the university’s Human Project, as it projects the scholarship of service and transformation leadership. It is an exceptional honour to be recognised by the UN and to receive this award,” says Lacea Loader, Director: Strategic Communication at the UFS.

“The MACE Higher and Further Education Excellence Awards provide an excellent platform to showcase the many projects and campaigns of the sector, and to receive this kind of recognition from our peers is a tremendous honour for the UFS,” says Loader.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept